• search hit 4 of 12
Back to Result List

Structure and function of mammalian aldehyde oxidases

  • Mammalian aldehyde oxidases (AOXs; EC1.2.3.1) are a group of conserved proteins belonging to the family of molybdo-flavoenzymes along with the structurally related xanthine dehydrogenase enzyme. AOXs are characterized by broad substrate specificity, oxidizing not only aromatic and aliphatic aldehydes into the corresponding carboxylic acids, but also hydroxylating a series of heteroaromatic rings. The number of AOX isoenzymes expressed in different vertebrate species is variable. The two extremes are represented by humans, which express a single enzyme (AOX1) in many organs and mice or rats which are characterized by tissue-specific expression of four isoforms (AOX1, AOX2, AOX3, and AOX4). In vertebrates each AOX isoenzyme is the product of a distinct gene consisting of 35 highly conserved exons. The extant species-specific complement of AOX isoenzymes is the result of a complex evolutionary process consisting of a first phase characterized by a series of asynchronous gene duplications and a second phase where the pseudogenization andMammalian aldehyde oxidases (AOXs; EC1.2.3.1) are a group of conserved proteins belonging to the family of molybdo-flavoenzymes along with the structurally related xanthine dehydrogenase enzyme. AOXs are characterized by broad substrate specificity, oxidizing not only aromatic and aliphatic aldehydes into the corresponding carboxylic acids, but also hydroxylating a series of heteroaromatic rings. The number of AOX isoenzymes expressed in different vertebrate species is variable. The two extremes are represented by humans, which express a single enzyme (AOX1) in many organs and mice or rats which are characterized by tissue-specific expression of four isoforms (AOX1, AOX2, AOX3, and AOX4). In vertebrates each AOX isoenzyme is the product of a distinct gene consisting of 35 highly conserved exons. The extant species-specific complement of AOX isoenzymes is the result of a complex evolutionary process consisting of a first phase characterized by a series of asynchronous gene duplications and a second phase where the pseudogenization and gene deletion events prevail. In the last few years remarkable advances in the elucidation of the structural characteristics and the catalytic mechanisms of mammalian AOXs have been made thanks to the successful crystallization of human AOX1 and mouse AOX3. Much less is known about the physiological function and physiological substrates of human AOX1 and other mammalian AOX isoenzymes, although the importance of these proteins in xenobiotic metabolism is fairly well established and their relevance in drug development is increasing. This review article provides an overview and a discussion of the current knowledge on mammalian AOX.show moreshow less

Export metadata

Additional Services

Search Google Scholar Statistics
Metadaten
Author details:Mineko Terao, Maria Joao Romao, Silke LeimkühlerORCiDGND, Marco Bolis, Maddalena Fratelli, Catarina Coelho, Teresa Santos-Silva, Enrico Garattini
DOI:https://doi.org/10.1007/s00204-016-1683-1
ISSN:0340-5761
ISSN:1432-0738
Pubmed ID:https://pubmed.ncbi.nlm.nih.gov/26920149
Title of parent work (English):Archives of toxicology : official journal of EUROTOX
Publisher:Springer
Place of publishing:Heidelberg
Publication type:Review
Language:English
Year of first publication:2016
Publication year:2016
Release date:2020/03/22
Tag:Aldehyde oxidase; Drug metabolism; Molybdo-flavoenzymes; Xanthine oxidoreductase
Volume:90
Number of pages:28
First page:753
Last Page:780
Funding institution:Fondazione Italo Monzino; Associazione Italiana per la Ricerca contro il Cancro (AIRC); Deutsche Forschungsgemeinschaft (DFG) [LE1171/8-1]; Fundacao para a Ciencia e Tecnologia [UID/Multi/04378/2013, PTDC/BBB-BEP/1185/2014, EXCL/QEQ-COM/0394/2012, PTDC/BIA-PRO/118377/2010, SFRH/BPD/84581/2012, DAAD-441.00]
Organizational units:Mathematisch-Naturwissenschaftliche Fakultät / Institut für Biochemie und Biologie
Peer review:Referiert
Accept ✔
This website uses technically necessary session cookies. By continuing to use the website, you agree to this. You can find our privacy policy here.